Journal of Healthcare Engineering-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1218660, encodeId=9fda12186609d, content=要投这个杂志，可以私我，又快又安全，正常投稿程序, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Wed May 11 09:28:35 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233064, encodeId=e14812330648c, content=偏重的研究方向：肿瘤 经验分享：我想问一下，投这个普刊，审稿一般多久呀，官网讲的40天左右，投了一周多了还是complete submission V1，编辑未分配，有没有老哥分享一下具体的时间节点啊，十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Sun Jul 17 23:32:32 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217005, encodeId=d55e121e005b5, content=pending approval 是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Thu May 05 10:39:51 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223151, encodeId=372f1223151ae, content=有消息称这杂志要被踢出sci了，是真的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06375534862, createdName=ms4000000947619634, createdTime=Sun May 29 13:46:35 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249390, encodeId=f90012493907a, content=速度很慢，submitted和ae invited来回切换了一个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Fri Sep 16 19:38:50 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197869, encodeId=9fab119e869ca, content=兄弟们，这个杂志编辑给了大修，修回后被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Feb 27 23:34:28 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108520, encodeId=2c65210852061, content=已经是第四稿了（三审结束），PENDING APPROVAL状态2个月了，是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/350bc6fc87f841cb9b9f0e452e53621a/ba5c417795064c429ae6b2b132afd63e.jpg, createdBy=206f5528694, createdName=ms9000001707738911, createdTime=Mon Jan 02 17:38:08 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238896, encodeId=48a81238896f0, content=我想问一下，有没有人投这个期刊的特刊：Computational Intelligence Techniques for Healthcare 4.0: Medical Image Analysis？？我投的时候看还有两篇已经接受的文章，现在看没有了。还有就是一直都没有分配编辑是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53678277783, createdName=ms1000000777589433, createdTime=Mon Aug 15 22:15:56 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228180, encodeId=c3661228180cb, content=审稿速度:3.0 经验分享：返修回去 under review后怎么一直是pending approval, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ad5508128, createdName=ms6000001647951052, createdTime=Thu Jun 23 10:26:24 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238733, encodeId=e6ae1238e335a, content=求解特刊是比普刊容易中吗？如果是那特刊是不是水分大呢...不知道学校认不认0.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd336577063, createdName=ms5000001232039368, createdTime=Mon Aug 15 08:53:27 CST 2022, time=2022-08-15, status=1, ipAttribution=)]

2022-05-11 ms7000000149540875

要投这个杂志，可以私我，又快又安全，正常投稿程序

62 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1218660, encodeId=9fda12186609d, content=要投这个杂志，可以私我，又快又安全，正常投稿程序, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Wed May 11 09:28:35 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233064, encodeId=e14812330648c, content=偏重的研究方向：肿瘤 经验分享：我想问一下，投这个普刊，审稿一般多久呀，官网讲的40天左右，投了一周多了还是complete submission V1，编辑未分配，有没有老哥分享一下具体的时间节点啊，十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Sun Jul 17 23:32:32 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217005, encodeId=d55e121e005b5, content=pending approval 是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Thu May 05 10:39:51 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223151, encodeId=372f1223151ae, content=有消息称这杂志要被踢出sci了，是真的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06375534862, createdName=ms4000000947619634, createdTime=Sun May 29 13:46:35 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249390, encodeId=f90012493907a, content=速度很慢，submitted和ae invited来回切换了一个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Fri Sep 16 19:38:50 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197869, encodeId=9fab119e869ca, content=兄弟们，这个杂志编辑给了大修，修回后被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Feb 27 23:34:28 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108520, encodeId=2c65210852061, content=已经是第四稿了（三审结束），PENDING APPROVAL状态2个月了，是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/350bc6fc87f841cb9b9f0e452e53621a/ba5c417795064c429ae6b2b132afd63e.jpg, createdBy=206f5528694, createdName=ms9000001707738911, createdTime=Mon Jan 02 17:38:08 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238896, encodeId=48a81238896f0, content=我想问一下，有没有人投这个期刊的特刊：Computational Intelligence Techniques for Healthcare 4.0: Medical Image Analysis？？我投的时候看还有两篇已经接受的文章，现在看没有了。还有就是一直都没有分配编辑是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53678277783, createdName=ms1000000777589433, createdTime=Mon Aug 15 22:15:56 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228180, encodeId=c3661228180cb, content=审稿速度:3.0 经验分享：返修回去 under review后怎么一直是pending approval, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ad5508128, createdName=ms6000001647951052, createdTime=Thu Jun 23 10:26:24 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238733, encodeId=e6ae1238e335a, content=求解特刊是比普刊容易中吗？如果是那特刊是不是水分大呢...不知道学校认不认0.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd336577063, createdName=ms5000001232039368, createdTime=Mon Aug 15 08:53:27 CST 2022, time=2022-08-15, status=1, ipAttribution=)]

2022-07-17 ms8000000524560535

偏重的研究方向：肿瘤
经验分享：我想问一下，投这个普刊，审稿一般多久呀，官网讲的40天左右，投了一周多了还是complete submission V1，编辑未分配，有没有老哥分享一下具体的时间节点啊，十分感谢

30 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1218660, encodeId=9fda12186609d, content=要投这个杂志，可以私我，又快又安全，正常投稿程序, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Wed May 11 09:28:35 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233064, encodeId=e14812330648c, content=偏重的研究方向：肿瘤 经验分享：我想问一下，投这个普刊，审稿一般多久呀，官网讲的40天左右，投了一周多了还是complete submission V1，编辑未分配，有没有老哥分享一下具体的时间节点啊，十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Sun Jul 17 23:32:32 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217005, encodeId=d55e121e005b5, content=pending approval 是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Thu May 05 10:39:51 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223151, encodeId=372f1223151ae, content=有消息称这杂志要被踢出sci了，是真的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06375534862, createdName=ms4000000947619634, createdTime=Sun May 29 13:46:35 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249390, encodeId=f90012493907a, content=速度很慢，submitted和ae invited来回切换了一个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Fri Sep 16 19:38:50 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197869, encodeId=9fab119e869ca, content=兄弟们，这个杂志编辑给了大修，修回后被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Feb 27 23:34:28 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108520, encodeId=2c65210852061, content=已经是第四稿了（三审结束），PENDING APPROVAL状态2个月了，是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/350bc6fc87f841cb9b9f0e452e53621a/ba5c417795064c429ae6b2b132afd63e.jpg, createdBy=206f5528694, createdName=ms9000001707738911, createdTime=Mon Jan 02 17:38:08 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238896, encodeId=48a81238896f0, content=我想问一下，有没有人投这个期刊的特刊：Computational Intelligence Techniques for Healthcare 4.0: Medical Image Analysis？？我投的时候看还有两篇已经接受的文章，现在看没有了。还有就是一直都没有分配编辑是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53678277783, createdName=ms1000000777589433, createdTime=Mon Aug 15 22:15:56 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228180, encodeId=c3661228180cb, content=审稿速度:3.0 经验分享：返修回去 under review后怎么一直是pending approval, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ad5508128, createdName=ms6000001647951052, createdTime=Thu Jun 23 10:26:24 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238733, encodeId=e6ae1238e335a, content=求解特刊是比普刊容易中吗？如果是那特刊是不是水分大呢...不知道学校认不认0.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd336577063, createdName=ms5000001232039368, createdTime=Mon Aug 15 08:53:27 CST 2022, time=2022-08-15, status=1, ipAttribution=)]

2022-05-05 玄琳

pending approval 是什么意思啊

48 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1218660, encodeId=9fda12186609d, content=要投这个杂志，可以私我，又快又安全，正常投稿程序, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Wed May 11 09:28:35 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233064, encodeId=e14812330648c, content=偏重的研究方向：肿瘤 经验分享：我想问一下，投这个普刊，审稿一般多久呀，官网讲的40天左右，投了一周多了还是complete submission V1，编辑未分配，有没有老哥分享一下具体的时间节点啊，十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Sun Jul 17 23:32:32 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217005, encodeId=d55e121e005b5, content=pending approval 是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Thu May 05 10:39:51 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223151, encodeId=372f1223151ae, content=有消息称这杂志要被踢出sci了，是真的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06375534862, createdName=ms4000000947619634, createdTime=Sun May 29 13:46:35 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249390, encodeId=f90012493907a, content=速度很慢，submitted和ae invited来回切换了一个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Fri Sep 16 19:38:50 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197869, encodeId=9fab119e869ca, content=兄弟们，这个杂志编辑给了大修，修回后被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Feb 27 23:34:28 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108520, encodeId=2c65210852061, content=已经是第四稿了（三审结束），PENDING APPROVAL状态2个月了，是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/350bc6fc87f841cb9b9f0e452e53621a/ba5c417795064c429ae6b2b132afd63e.jpg, createdBy=206f5528694, createdName=ms9000001707738911, createdTime=Mon Jan 02 17:38:08 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238896, encodeId=48a81238896f0, content=我想问一下，有没有人投这个期刊的特刊：Computational Intelligence Techniques for Healthcare 4.0: Medical Image Analysis？？我投的时候看还有两篇已经接受的文章，现在看没有了。还有就是一直都没有分配编辑是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53678277783, createdName=ms1000000777589433, createdTime=Mon Aug 15 22:15:56 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228180, encodeId=c3661228180cb, content=审稿速度:3.0 经验分享：返修回去 under review后怎么一直是pending approval, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ad5508128, createdName=ms6000001647951052, createdTime=Thu Jun 23 10:26:24 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238733, encodeId=e6ae1238e335a, content=求解特刊是比普刊容易中吗？如果是那特刊是不是水分大呢...不知道学校认不认0.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd336577063, createdName=ms5000001232039368, createdTime=Mon Aug 15 08:53:27 CST 2022, time=2022-08-15, status=1, ipAttribution=)]

2022-05-29 ms4000000947619634

有消息称这杂志要被踢出sci了，是真的吗

54 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1218660, encodeId=9fda12186609d, content=要投这个杂志，可以私我，又快又安全，正常投稿程序, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Wed May 11 09:28:35 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233064, encodeId=e14812330648c, content=偏重的研究方向：肿瘤 经验分享：我想问一下，投这个普刊，审稿一般多久呀，官网讲的40天左右，投了一周多了还是complete submission V1，编辑未分配，有没有老哥分享一下具体的时间节点啊，十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Sun Jul 17 23:32:32 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217005, encodeId=d55e121e005b5, content=pending approval 是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Thu May 05 10:39:51 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223151, encodeId=372f1223151ae, content=有消息称这杂志要被踢出sci了，是真的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06375534862, createdName=ms4000000947619634, createdTime=Sun May 29 13:46:35 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249390, encodeId=f90012493907a, content=速度很慢，submitted和ae invited来回切换了一个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Fri Sep 16 19:38:50 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197869, encodeId=9fab119e869ca, content=兄弟们，这个杂志编辑给了大修，修回后被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Feb 27 23:34:28 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108520, encodeId=2c65210852061, content=已经是第四稿了（三审结束），PENDING APPROVAL状态2个月了，是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/350bc6fc87f841cb9b9f0e452e53621a/ba5c417795064c429ae6b2b132afd63e.jpg, createdBy=206f5528694, createdName=ms9000001707738911, createdTime=Mon Jan 02 17:38:08 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238896, encodeId=48a81238896f0, content=我想问一下，有没有人投这个期刊的特刊：Computational Intelligence Techniques for Healthcare 4.0: Medical Image Analysis？？我投的时候看还有两篇已经接受的文章，现在看没有了。还有就是一直都没有分配编辑是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53678277783, createdName=ms1000000777589433, createdTime=Mon Aug 15 22:15:56 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228180, encodeId=c3661228180cb, content=审稿速度:3.0 经验分享：返修回去 under review后怎么一直是pending approval, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ad5508128, createdName=ms6000001647951052, createdTime=Thu Jun 23 10:26:24 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238733, encodeId=e6ae1238e335a, content=求解特刊是比普刊容易中吗？如果是那特刊是不是水分大呢...不知道学校认不认0.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd336577063, createdName=ms5000001232039368, createdTime=Mon Aug 15 08:53:27 CST 2022, time=2022-08-15, status=1, ipAttribution=)]

2022-09-16 14862b90m09(暂无昵称)

速度很慢，submitted和ae invited来回切换了一个多月

37 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1218660, encodeId=9fda12186609d, content=要投这个杂志，可以私我，又快又安全，正常投稿程序, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Wed May 11 09:28:35 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233064, encodeId=e14812330648c, content=偏重的研究方向：肿瘤 经验分享：我想问一下，投这个普刊，审稿一般多久呀，官网讲的40天左右，投了一周多了还是complete submission V1，编辑未分配，有没有老哥分享一下具体的时间节点啊，十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Sun Jul 17 23:32:32 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217005, encodeId=d55e121e005b5, content=pending approval 是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Thu May 05 10:39:51 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223151, encodeId=372f1223151ae, content=有消息称这杂志要被踢出sci了，是真的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06375534862, createdName=ms4000000947619634, createdTime=Sun May 29 13:46:35 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249390, encodeId=f90012493907a, content=速度很慢，submitted和ae invited来回切换了一个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Fri Sep 16 19:38:50 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197869, encodeId=9fab119e869ca, content=兄弟们，这个杂志编辑给了大修，修回后被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Feb 27 23:34:28 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108520, encodeId=2c65210852061, content=已经是第四稿了（三审结束），PENDING APPROVAL状态2个月了，是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/350bc6fc87f841cb9b9f0e452e53621a/ba5c417795064c429ae6b2b132afd63e.jpg, createdBy=206f5528694, createdName=ms9000001707738911, createdTime=Mon Jan 02 17:38:08 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238896, encodeId=48a81238896f0, content=我想问一下，有没有人投这个期刊的特刊：Computational Intelligence Techniques for Healthcare 4.0: Medical Image Analysis？？我投的时候看还有两篇已经接受的文章，现在看没有了。还有就是一直都没有分配编辑是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53678277783, createdName=ms1000000777589433, createdTime=Mon Aug 15 22:15:56 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228180, encodeId=c3661228180cb, content=审稿速度:3.0 经验分享：返修回去 under review后怎么一直是pending approval, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ad5508128, createdName=ms6000001647951052, createdTime=Thu Jun 23 10:26:24 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238733, encodeId=e6ae1238e335a, content=求解特刊是比普刊容易中吗？如果是那特刊是不是水分大呢...不知道学校认不认0.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd336577063, createdName=ms5000001232039368, createdTime=Mon Aug 15 08:53:27 CST 2022, time=2022-08-15, status=1, ipAttribution=)]

2022-02-27 ms2000001076054986

兄弟们，这个杂志编辑给了大修，修回后被拒的概率大吗

34 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1218660, encodeId=9fda12186609d, content=要投这个杂志，可以私我，又快又安全，正常投稿程序, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Wed May 11 09:28:35 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233064, encodeId=e14812330648c, content=偏重的研究方向：肿瘤 经验分享：我想问一下，投这个普刊，审稿一般多久呀，官网讲的40天左右，投了一周多了还是complete submission V1，编辑未分配，有没有老哥分享一下具体的时间节点啊，十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Sun Jul 17 23:32:32 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217005, encodeId=d55e121e005b5, content=pending approval 是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Thu May 05 10:39:51 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223151, encodeId=372f1223151ae, content=有消息称这杂志要被踢出sci了，是真的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06375534862, createdName=ms4000000947619634, createdTime=Sun May 29 13:46:35 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249390, encodeId=f90012493907a, content=速度很慢，submitted和ae invited来回切换了一个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Fri Sep 16 19:38:50 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197869, encodeId=9fab119e869ca, content=兄弟们，这个杂志编辑给了大修，修回后被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Feb 27 23:34:28 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108520, encodeId=2c65210852061, content=已经是第四稿了（三审结束），PENDING APPROVAL状态2个月了，是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/350bc6fc87f841cb9b9f0e452e53621a/ba5c417795064c429ae6b2b132afd63e.jpg, createdBy=206f5528694, createdName=ms9000001707738911, createdTime=Mon Jan 02 17:38:08 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238896, encodeId=48a81238896f0, content=我想问一下，有没有人投这个期刊的特刊：Computational Intelligence Techniques for Healthcare 4.0: Medical Image Analysis？？我投的时候看还有两篇已经接受的文章，现在看没有了。还有就是一直都没有分配编辑是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53678277783, createdName=ms1000000777589433, createdTime=Mon Aug 15 22:15:56 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228180, encodeId=c3661228180cb, content=审稿速度:3.0 经验分享：返修回去 under review后怎么一直是pending approval, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ad5508128, createdName=ms6000001647951052, createdTime=Thu Jun 23 10:26:24 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238733, encodeId=e6ae1238e335a, content=求解特刊是比普刊容易中吗？如果是那特刊是不是水分大呢...不知道学校认不认0.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd336577063, createdName=ms5000001232039368, createdTime=Mon Aug 15 08:53:27 CST 2022, time=2022-08-15, status=1, ipAttribution=)]

2023-01-02 ms9000001707738911 来自河南省

已经是第四稿了（三审结束），PENDING APPROVAL状态2个月了，是什么情况呢？

56 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1218660, encodeId=9fda12186609d, content=要投这个杂志，可以私我，又快又安全，正常投稿程序, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Wed May 11 09:28:35 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233064, encodeId=e14812330648c, content=偏重的研究方向：肿瘤 经验分享：我想问一下，投这个普刊，审稿一般多久呀，官网讲的40天左右，投了一周多了还是complete submission V1，编辑未分配，有没有老哥分享一下具体的时间节点啊，十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Sun Jul 17 23:32:32 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217005, encodeId=d55e121e005b5, content=pending approval 是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Thu May 05 10:39:51 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223151, encodeId=372f1223151ae, content=有消息称这杂志要被踢出sci了，是真的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06375534862, createdName=ms4000000947619634, createdTime=Sun May 29 13:46:35 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249390, encodeId=f90012493907a, content=速度很慢，submitted和ae invited来回切换了一个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Fri Sep 16 19:38:50 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197869, encodeId=9fab119e869ca, content=兄弟们，这个杂志编辑给了大修，修回后被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Feb 27 23:34:28 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108520, encodeId=2c65210852061, content=已经是第四稿了（三审结束），PENDING APPROVAL状态2个月了，是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/350bc6fc87f841cb9b9f0e452e53621a/ba5c417795064c429ae6b2b132afd63e.jpg, createdBy=206f5528694, createdName=ms9000001707738911, createdTime=Mon Jan 02 17:38:08 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238896, encodeId=48a81238896f0, content=我想问一下，有没有人投这个期刊的特刊：Computational Intelligence Techniques for Healthcare 4.0: Medical Image Analysis？？我投的时候看还有两篇已经接受的文章，现在看没有了。还有就是一直都没有分配编辑是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53678277783, createdName=ms1000000777589433, createdTime=Mon Aug 15 22:15:56 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228180, encodeId=c3661228180cb, content=审稿速度:3.0 经验分享：返修回去 under review后怎么一直是pending approval, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ad5508128, createdName=ms6000001647951052, createdTime=Thu Jun 23 10:26:24 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238733, encodeId=e6ae1238e335a, content=求解特刊是比普刊容易中吗？如果是那特刊是不是水分大呢...不知道学校认不认0.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd336577063, createdName=ms5000001232039368, createdTime=Mon Aug 15 08:53:27 CST 2022, time=2022-08-15, status=1, ipAttribution=)]

2022-08-15 ms1000000777589433

我想问一下，有没有人投这个期刊的特刊：Computational Intelligence Techniques for Healthcare 4.0: Medical Image Analysis？？我投的时候看还有两篇已经接受的文章，现在看没有了。还有就是一直都没有分配编辑是什么情况呀？

58 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1218660, encodeId=9fda12186609d, content=要投这个杂志，可以私我，又快又安全，正常投稿程序, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Wed May 11 09:28:35 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233064, encodeId=e14812330648c, content=偏重的研究方向：肿瘤 经验分享：我想问一下，投这个普刊，审稿一般多久呀，官网讲的40天左右，投了一周多了还是complete submission V1，编辑未分配，有没有老哥分享一下具体的时间节点啊，十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Sun Jul 17 23:32:32 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217005, encodeId=d55e121e005b5, content=pending approval 是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Thu May 05 10:39:51 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223151, encodeId=372f1223151ae, content=有消息称这杂志要被踢出sci了，是真的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06375534862, createdName=ms4000000947619634, createdTime=Sun May 29 13:46:35 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249390, encodeId=f90012493907a, content=速度很慢，submitted和ae invited来回切换了一个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Fri Sep 16 19:38:50 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197869, encodeId=9fab119e869ca, content=兄弟们，这个杂志编辑给了大修，修回后被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Feb 27 23:34:28 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108520, encodeId=2c65210852061, content=已经是第四稿了（三审结束），PENDING APPROVAL状态2个月了，是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/350bc6fc87f841cb9b9f0e452e53621a/ba5c417795064c429ae6b2b132afd63e.jpg, createdBy=206f5528694, createdName=ms9000001707738911, createdTime=Mon Jan 02 17:38:08 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238896, encodeId=48a81238896f0, content=我想问一下，有没有人投这个期刊的特刊：Computational Intelligence Techniques for Healthcare 4.0: Medical Image Analysis？？我投的时候看还有两篇已经接受的文章，现在看没有了。还有就是一直都没有分配编辑是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53678277783, createdName=ms1000000777589433, createdTime=Mon Aug 15 22:15:56 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228180, encodeId=c3661228180cb, content=审稿速度:3.0 经验分享：返修回去 under review后怎么一直是pending approval, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ad5508128, createdName=ms6000001647951052, createdTime=Thu Jun 23 10:26:24 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238733, encodeId=e6ae1238e335a, content=求解特刊是比普刊容易中吗？如果是那特刊是不是水分大呢...不知道学校认不认0.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd336577063, createdName=ms5000001232039368, createdTime=Mon Aug 15 08:53:27 CST 2022, time=2022-08-15, status=1, ipAttribution=)]

2022-06-23 ms6000001647951052

审稿速度:3.0
经验分享：返修回去 under review后怎么一直是pending approval

25 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1218660, encodeId=9fda12186609d, content=要投这个杂志，可以私我，又快又安全，正常投稿程序, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Wed May 11 09:28:35 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233064, encodeId=e14812330648c, content=偏重的研究方向：肿瘤 经验分享：我想问一下，投这个普刊，审稿一般多久呀，官网讲的40天左右，投了一周多了还是complete submission V1，编辑未分配，有没有老哥分享一下具体的时间节点啊，十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Sun Jul 17 23:32:32 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217005, encodeId=d55e121e005b5, content=pending approval 是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Thu May 05 10:39:51 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223151, encodeId=372f1223151ae, content=有消息称这杂志要被踢出sci了，是真的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06375534862, createdName=ms4000000947619634, createdTime=Sun May 29 13:46:35 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249390, encodeId=f90012493907a, content=速度很慢，submitted和ae invited来回切换了一个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Fri Sep 16 19:38:50 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197869, encodeId=9fab119e869ca, content=兄弟们，这个杂志编辑给了大修，修回后被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Feb 27 23:34:28 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108520, encodeId=2c65210852061, content=已经是第四稿了（三审结束），PENDING APPROVAL状态2个月了，是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/350bc6fc87f841cb9b9f0e452e53621a/ba5c417795064c429ae6b2b132afd63e.jpg, createdBy=206f5528694, createdName=ms9000001707738911, createdTime=Mon Jan 02 17:38:08 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238896, encodeId=48a81238896f0, content=我想问一下，有没有人投这个期刊的特刊：Computational Intelligence Techniques for Healthcare 4.0: Medical Image Analysis？？我投的时候看还有两篇已经接受的文章，现在看没有了。还有就是一直都没有分配编辑是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53678277783, createdName=ms1000000777589433, createdTime=Mon Aug 15 22:15:56 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228180, encodeId=c3661228180cb, content=审稿速度:3.0 经验分享：返修回去 under review后怎么一直是pending approval, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ad5508128, createdName=ms6000001647951052, createdTime=Thu Jun 23 10:26:24 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238733, encodeId=e6ae1238e335a, content=求解特刊是比普刊容易中吗？如果是那特刊是不是水分大呢...不知道学校认不认0.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd336577063, createdName=ms5000001232039368, createdTime=Mon Aug 15 08:53:27 CST 2022, time=2022-08-15, status=1, ipAttribution=)]

2022-08-15 ms5000001232039368

求解特刊是比普刊容易中吗？如果是那特刊是不是水分大呢...不知道学校认不认0.0

31 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务